Business Context and Reporting Period
This Form 6-K filing by uniQure N.V. reports the results of the 2015 Annual General Meeting of Shareholders (AGM) held on June 10, 2015. The filing confirms that all proposed resolutions were passed by the shareholders.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and shareholder voting outcomes.
Material Changes and Voting Results
Shareholders voted on 14 agenda items. Key outcomes include:
- Annual Report Adoption: The 2014 annual report and accounts were adopted with 12,554,569 votes in favor.
- Board Discharge: Both the Management Board and Supervisory Board were granted discharge for the 2014 financial year.
- Auditor Reappointment: PricewaterhouseCoopers Accountants N.V. was reappointed as the external auditor for 2015.
- Board Appointments: Mr. Kapusta was appointed to the Management Board (term ending 2019), and Mr. Astley-Sparke was appointed to the Supervisory Board (term ending 2018).
- Share Issuance Authority: The Management Board was authorized to issue ordinary shares for 18 months, including the exclusion of pre-emptive rights for the BMS Transaction.
- Share Repurchase: The Management Board was authorized to repurchase ordinary shares, subject to Supervisory Board approval.
- Contested Votes: Agenda Items 10 (Supervisory Board Remuneration), 13a (Share Incentive Plan Amendment), and 13b (Issuance under Amended Plan) received significant opposition, with approximately 27-38% of votes cast against these proposals.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, or specific risk factors. The primary operational context provided is the shareholder approval of the BMS Transaction share issuance and the authorization of share repurchases.
Investor Verification Checklist
- Verify the specific terms and financial impact of the "BMS Transaction" referenced in Agenda Item 12.
- Review the 2014 Annual Report and Accounts (Agenda Item 4) for detailed financial performance, as this filing only confirms their adoption.
- Assess the implications of the significant opposition (approx. 38%) to the Supervisory Board remuneration and Share Incentive Plan amendments.
- Confirm the details of the share repurchase program authorized under Agenda Item 14, including any limits on the number of shares or price.